← Back to Search

Surgical Mesh

Mesh-Reduced Sling for Stress Urinary Incontinence

N/A
Recruiting
Led By Henry Chill, MD
Research Sponsored by NorthShore University HealthSystem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Symptomatic stress urinary incontinence
Be older than 18 years old
Must not have
Previous stress urinary incontinence surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post-op
Awards & highlights

Summary

This trial will test a new procedure to treat SUI in women, assessing its safety and effectiveness.

Who is the study for?
This trial is for women with stress urinary incontinence, which means they leak urine under pressure like coughing or lifting. It's not for women who can still have children (ages 0-45) or those who've had surgery for this issue before.
What is being tested?
The study tests a new surgical technique using a mesh-reduced sling to treat stress urinary incontinence. Women will be assessed before and up to one year after the operation, including symptom checks and pelvic exams.
What are the potential side effects?
While specific side effects are not listed, typical risks of such surgeries may include pain at the site, infection risk, bleeding, and potential complications related to the mesh material used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience urine leakage when I cough, sneeze, or exercise.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had surgery for stress urinary incontinence before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post-op for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PFDI-20 score
Secondary study objectives
Complication measured by distal urethral swing angle
Complication measured by early and remote post-operative complications
Complication measured by proximal urethral swing angle

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mesh-reduced SlingExperimental Treatment1 Intervention
Mesh-reduced sling will improve stress urinary incontinence (SUI) symptoms in women with SUI and normal urethral closure pressure at 2 months and 12 months after surgery.

Find a Location

Who is running the clinical trial?

NorthShore University HealthSystemLead Sponsor
132 Previous Clinical Trials
737,627 Total Patients Enrolled
Henry Chill, MDPrincipal InvestigatorNorthShore University HealthSystem
1 Previous Clinical Trials
190 Total Patients Enrolled

Media Library

Mesh-reduced Sling (Surgical Mesh) Clinical Trial Eligibility Overview. Trial Name: NCT05842005 — N/A
Stress Incontinence Research Study Groups: Mesh-reduced Sling
Stress Incontinence Clinical Trial 2023: Mesh-reduced Sling Highlights & Side Effects. Trial Name: NCT05842005 — N/A
Mesh-reduced Sling (Surgical Mesh) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05842005 — N/A
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top